Provident Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Provident Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.3K	Hold	300	–	–	0.01%	120
2025 Q4	$36.6K	Hold	300	–	–	0.01%	123
2025 Q3	$30.1K	Hold	300	–	–	0.01%	124
2025 Q2	$24.9K	Sell	300 -10	-3%	-$798	0.01%	122
2025 Q1	$25.1K	Buy	310 +300	+3,000%	+$26.8K	0.01%	120
2024 Q4	$901	Buy	+10	New	+$969	﹤0.01%	122
2023 Q2	–	Sell	-50	Closed	-$3.81K	–	101
2023 Q1	$3.81K	Buy	+50	New	+$4.15K	﹤0.01%	89

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Provident Wealth Management's XBI Position: Q1 2026 in Review

Provident Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 300 shares worth $38.3K. The position accounts for 0.01% of the portfolio, ranked #120.

Provident Wealth Management first reported a position in XBI in Q1 2023 and has held it in 7 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Provident Wealth Management held 300 shares of State Street SPDR S&P Biotech ETF worth $38.3K as of Q1 2026.
Provident Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Provident Wealth Management's portfolio in Q1 2026, its #120 holding.
Provident Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and has held it in 7 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Provident Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.